The IBC is responsible for reviewing projects in which biohazards are used ensuring that research is conducted safely and that risks are assessed and minimized – see IBC Charge. The IBC reviews and approves projects and issues Biohazard Use Authorization (BUA) permits per the standard operating procedure: SOP IBC BUA Review and Approval Process. Visit the Biohazard Use Authorization (BUA) web page to register, renew, or amend a BUA.
Additionally, Human Gene Transfer (HGT) clinical trials need to be reviewed by an IBC. Before HGT clinical trials can commence, the study teams need to fulfill a specific set of requirements before they can be approved by the IBC. Read more about the IBC approval process for HGT clinical trials.
IBC Deadlines and Meeting Dates
| Protocol Submission Deadline | IBC Meeting Dates | Zoom |
|---|---|---|
| February 6, 2025 | February 27, 2025 | SBA 329 or Zoom>> |
| March 6, 2025 | March 27, 2025 | Zoom>> |
| April 3, 2025 | April 24, 2025 | Zoom>> |
| May 8, 2025 | May 29, 2025 | SBA 329 or Zoom>> |
| June 5, 2025 | June 26, 2025 | Zoom>> |
| July 10, 2025 | July 31, 2025 | Zoom>> |
| August 7, 2025 | August 28, 2025 | SBA 329 or Zoom>> |
| September 4, 2025 | September 25, 2025 | Zoom>> |
| October 2, 2025 | October 23, 2025 | Zoom>> |